NASDAQ
Pliant Therapeutics, Inc. (PLRX)
♥ 350 Thanks from members
Pliant Therapeutics, Inc. (PLRX) is experiencing compressed trading near its lower bounds around $1.07 to $1.26, though market attention received a positive lift from the FDA Fast Track designation granted to its investigational drug PLN-101095 for fibrotic diseases and solid tumors.